aluates Reports

$ 0.0

Automative

Insulin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: March 2024

Report Code: QYRE-Auto-14L12146

Global Insulin API Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

BUY CHAPTERS

Insulin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14L12146

Report

March 2024

Pages:122

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Sanofi Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon Ltd.

Amphastar

WOCKHARDT

Julphar Diabetes

Torrent Pharma

Insulin API - Market Size

The global market for Insulin API was estimated to be worth US$ 1745.6 million in 2023 and is forecast to a readjusted size of US$ 2137.4 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

Insulin API - Market

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin API by region & country, by Type, and by Application.

The Insulin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin API.

Market Segmentation

Scope of Insulin API - Market Report

Report Metric	Details
Report Name	Insulin API - Market
Forecasted market size in 2030	US$ 2137.4 million
CAGR	2.9%
Forecasted years	2024 - 2030
Segment by Type:	Regular Human Insulin Insulin Analogue
Segment by Application	Fast-Acting Premix Long-Acting
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Insulin API - Market size in 2030?

Ans: The Insulin API - Market size in 2030 will be US$ 2137.4 million.

What is the market share of major companies in Insulin API - Market?

Ans: The top 2 players occupy over 65% shares of the global market.

What is the Insulin API - Market share by type?

Ans: Insulin Analogue is the main market, and occupies about 90% of the global market.

What is the Insulin API - Market share by application?

Ans: Long-Acting is the main type, with a share over 40%.

Who are the main players in the Insulin API - Market report?

Ans: The main players in the Insulin API - Market are Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma

What are the Application segmentation covered in the Insulin API - Market report?

Ans: The Applications covered in the Insulin API - Market report are Fast-Acting, Premix, Long-Acting

What are the Type segmentation covered in the Insulin API - Market report?

Ans: The Types covered in the Insulin API - Market report are Regular Human Insulin, Insulin Analogue

1 Market Overview

1.1 Insulin API Product Introduction

1.2 Global Insulin API Market Size Forecast

1.2.1 Global Insulin API Sales Value (2019-2030)

1.2.2 Global Insulin API Sales Volume (2019-2030)

1.2.3 Global Insulin API Sales Price (2019-2030)

1.3 Insulin API Market Trends & Drivers

1.3.1 Insulin API Industry Trends

1.3.2 Insulin API Market Drivers & Opportunity

1.3.3 Insulin API Market Challenges

1.3.4 Insulin API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Insulin API Players Revenue Ranking (2023)

2.2 Global Insulin API Revenue by Company (2019-2024)

2.3 Global Insulin API Players Sales Volume Ranking (2023)

2.4 Global Insulin API Sales Volume by Company Players (2019-2024)

2.5 Global Insulin API Average Price by Company (2019-2024)

2.6 Key Manufacturers Insulin API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Insulin API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Insulin API

2.9 Insulin API Market Competitive Analysis

2.9.1 Insulin API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Insulin API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Regular Human Insulin

3.1.2 Insulin Analogue

3.2 Global Insulin API Sales Value by Type

3.2.1 Global Insulin API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Insulin API Sales Value, by Type (2019-2030)

3.2.3 Global Insulin API Sales Value, by Type (%) (2019-2030)

3.3 Global Insulin API Sales Volume by Type

3.3.1 Global Insulin API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Insulin API Sales Volume, by Type (2019-2030)

3.3.3 Global Insulin API Sales Volume, by Type (%) (2019-2030)

3.4 Global Insulin API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Fast-Acting

4.1.2 Premix

4.1.3 Long-Acting

4.2 Global Insulin API Sales Value by Application

4.2.1 Global Insulin API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Insulin API Sales Value, by Application (2019-2030)

4.2.3 Global Insulin API Sales Value, by Application (%) (2019-2030)

4.3 Global Insulin API Sales Volume by Application

4.3.1 Global Insulin API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Insulin API Sales Volume, by Application (2019-2030)

4.3.3 Global Insulin API Sales Volume, by Application (%) (2019-2030)

4.4 Global Insulin API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Insulin API Sales Value by Region

5.1.1 Global Insulin API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Insulin API Sales Value by Region (2019-2024)

5.1.3 Global Insulin API Sales Value by Region (2025-2030)

5.1.4 Global Insulin API Sales Value by Region (%), (2019-2030)

5.2 Global Insulin API Sales Volume by Region

5.2.1 Global Insulin API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Insulin API Sales Volume by Region (2019-2024)

5.2.3 Global Insulin API Sales Volume by Region (2025-2030)

5.2.4 Global Insulin API Sales Volume by Region (%), (2019-2030)

5.3 Global Insulin API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Insulin API Sales Value, 2019-2030

5.4.2 North America Insulin API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Insulin API Sales Value, 2019-2030

5.5.2 Europe Insulin API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Insulin API Sales Value, 2019-2030

5.6.2 Asia Pacific Insulin API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Insulin API Sales Value, 2019-2030

5.7.2 South America Insulin API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Insulin API Sales Value, 2019-2030

5.8.2 Middle East & Africa Insulin API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Insulin API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Insulin API Sales Value

6.2.1 Key Countries/Regions Insulin API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Insulin API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Insulin API Sales Value, 2019-2030

6.3.2 United States Insulin API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Insulin API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Insulin API Sales Value, 2019-2030

6.4.2 Europe Insulin API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Insulin API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Insulin API Sales Value, 2019-2030

6.5.2 China Insulin API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Insulin API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Insulin API Sales Value, 2019-2030

6.6.2 Japan Insulin API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Insulin API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Insulin API Sales Value, 2019-2030

6.7.2 South Korea Insulin API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Insulin API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Insulin API Sales Value, 2019-2030

6.8.2 Southeast Asia Insulin API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Insulin API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Insulin API Sales Value, 2019-2030

6.9.2 India Insulin API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Insulin API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novo Nordisk

7.1.1 Novo Nordisk Company Information

7.1.2 Novo Nordisk Introduction and Business Overview

7.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novo Nordisk Insulin API Product Offerings

7.1.5 Novo Nordisk Recent Development

7.2 Sanofi-Aventis

7.2.1 Sanofi-Aventis Company Information

7.2.2 Sanofi-Aventis Introduction and Business Overview

7.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi-Aventis Insulin API Product Offerings

7.2.5 Sanofi-Aventis Recent Development

7.3 Eli Lilly

7.3.1 Eli Lilly Company Information

7.3.2 Eli Lilly Introduction and Business Overview

7.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lilly Insulin API Product Offerings

7.3.5 Eli Lilly Recent Development

7.4 Tonghua Dongbao

7.4.1 Tonghua Dongbao Company Information

7.4.2 Tonghua Dongbao Introduction and Business Overview

7.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Tonghua Dongbao Insulin API Product Offerings

7.4.5 Tonghua Dongbao Recent Development

7.5 Ganlee

7.5.1 Ganlee Company Information

7.5.2 Ganlee Introduction and Business Overview

7.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Ganlee Insulin API Product Offerings

7.5.5 Ganlee Recent Development

7.6 United Laboratory

7.6.1 United Laboratory Company Information

7.6.2 United Laboratory Introduction and Business Overview

7.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 United Laboratory Insulin API Product Offerings

7.6.5 United Laboratory Recent Development

7.7 Biocon

7.7.1 Biocon Company Information

7.7.2 Biocon Introduction and Business Overview

7.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Biocon Insulin API Product Offerings

7.7.5 Biocon Recent Development

7.8 Amphastar

7.8.1 Amphastar Company Information

7.8.2 Amphastar Introduction and Business Overview

7.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Amphastar Insulin API Product Offerings

7.8.5 Amphastar Recent Development

7.9 Wockhardt

7.9.1 Wockhardt Company Information

7.9.2 Wockhardt Introduction and Business Overview

7.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Wockhardt Insulin API Product Offerings

7.9.5 Wockhardt Recent Development

7.10 Julphar Diabetes

7.10.1 Julphar Diabetes Company Information

7.10.2 Julphar Diabetes Introduction and Business Overview

7.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Julphar Diabetes Insulin API Product Offerings

7.10.5 Julphar Diabetes Recent Development

7.11 Torrent Pharma

7.11.1 Torrent Pharma Company Information

7.11.2 Torrent Pharma Introduction and Business Overview

7.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Torrent Pharma Insulin API Product Offerings

7.11.5 Torrent Pharma Recent Development

8 Industry Chain Analysis

8.1 Insulin API Industrial Chain

8.2 Insulin API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Insulin API Sales Model

8.5.2 Sales Channel

8.5.3 Insulin API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Sanofi Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon Ltd.

Amphastar

WOCKHARDT

Julphar Diabetes

Torrent Pharma

List of Tables

Table 1. Insulin API Market Trends

Table 2. Insulin API Market Drivers & Opportunity

Table 3. Insulin API Market Challenges

Table 4. Insulin API Market Restraints

Table 5. Global Insulin API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Insulin API Revenue Market Share by Company (2019-2024)

Table 7. Global Insulin API Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Insulin API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Insulin API Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Insulin API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Insulin API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Insulin API

Table 13. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Insulin API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Insulin API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Insulin API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Insulin API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Insulin API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Insulin API Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Insulin API Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Insulin API Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Insulin API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Insulin API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Insulin API Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Insulin API Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Insulin API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Insulin API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Insulin API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Insulin API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Insulin API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Insulin API Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Insulin API Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Insulin API Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Insulin API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Insulin API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Insulin API Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Insulin API Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Insulin API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Insulin API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Insulin API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Insulin API Sales Value by Region (2019-2024) & (%)

Table 44. Global Insulin API Sales Value by Region (2025-2030) & (%)

Table 45. Global Insulin API Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Insulin API Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Insulin API Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Insulin API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Insulin API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Insulin API Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Insulin API Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Insulin API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Insulin API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Insulin API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Insulin API Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Insulin API Sales Volume, (2025-2030) & (K Units)

Table 57. Novo Nordisk Company Information

Table 58. Novo Nordisk Introduction and Business Overview

Table 59. Novo Nordisk Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Novo Nordisk Insulin API Product Offerings

Table 61. Novo Nordisk Recent Development

Table 62. Sanofi-Aventis Company Information

Table 63. Sanofi-Aventis Introduction and Business Overview

Table 64. Sanofi-Aventis Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Sanofi-Aventis Insulin API Product Offerings

Table 66. Sanofi-Aventis Recent Development

Table 67. Eli Lilly Company Information

Table 68. Eli Lilly Introduction and Business Overview

Table 69. Eli Lilly Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Eli Lilly Insulin API Product Offerings

Table 71. Eli Lilly Recent Development

Table 72. Tonghua Dongbao Company Information

Table 73. Tonghua Dongbao Introduction and Business Overview

Table 74. Tonghua Dongbao Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Tonghua Dongbao Insulin API Product Offerings

Table 76. Tonghua Dongbao Recent Development

Table 77. Ganlee Company Information

Table 78. Ganlee Introduction and Business Overview

Table 79. Ganlee Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Ganlee Insulin API Product Offerings

Table 81. Ganlee Recent Development

Table 82. United Laboratory Company Information

Table 83. United Laboratory Introduction and Business Overview

Table 84. United Laboratory Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. United Laboratory Insulin API Product Offerings

Table 86. United Laboratory Recent Development

Table 87. Biocon Company Information

Table 88. Biocon Introduction and Business Overview

Table 89. Biocon Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Biocon Insulin API Product Offerings

Table 91. Biocon Recent Development

Table 92. Amphastar Company Information

Table 93. Amphastar Introduction and Business Overview

Table 94. Amphastar Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Amphastar Insulin API Product Offerings

Table 96. Amphastar Recent Development

Table 97. Wockhardt Company Information

Table 98. Wockhardt Introduction and Business Overview

Table 99. Wockhardt Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Wockhardt Insulin API Product Offerings

Table 101. Wockhardt Recent Development

Table 102. Julphar Diabetes Company Information

Table 103. Julphar Diabetes Introduction and Business Overview

Table 104. Julphar Diabetes Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Julphar Diabetes Insulin API Product Offerings

Table 106. Julphar Diabetes Recent Development

Table 107. Torrent Pharma Company Information

Table 108. Torrent Pharma Introduction and Business Overview

Table 109. Torrent Pharma Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Torrent Pharma Insulin API Product Offerings

Table 111. Torrent Pharma Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Insulin API Downstream Customers

Table 115. Insulin API Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Insulin API Product Picture

Figure 2. Global Insulin API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Insulin API Sales Volume (2019-2030) & (K Units)

Figure 5. Global Insulin API Sales Price (2019-2030) & (USD/Unit)

Figure 6. Insulin API Report Years Considered

Figure 7. Global Insulin API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Insulin API Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin API Revenue in 2023

Figure 10. Insulin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Regular Human Insulin Picture

Figure 12. Insulin Analogue Picture

Figure 13. Global Insulin API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Insulin API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Insulin API Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Insulin API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Insulin API Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Fast-Acting

Figure 19. Product Picture of Premix

Figure 20. Product Picture of Long-Acting

Figure 21. Global Insulin API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Insulin API Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Insulin API Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Insulin API Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Insulin API Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Insulin API Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Insulin API Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Insulin API Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Insulin API Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Insulin API Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Insulin API Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Insulin API Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Insulin API Sales Volume (%), (2019-2030)

Figure 38. United States Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 44. China Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 46. China Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 56. India Insulin API Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Insulin API Sales Value by Type (%), 2023 VS 2030

Figure 58. India Insulin API Sales Value by Application (%), 2023 VS 2030

Figure 59. Insulin API Industrial Chain

Figure 60. Insulin API Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions